期刊文献+

脂联素与高血压关系的研究进展 被引量:3

暂未订购
导出
摘要 脂联素(adiponectin)是近年来发现的脂肪细胞因子之一,在人的血浆中含量丰富,具有抗动脉粥样硬化、改善胰岛素抵抗、降血糖、抗炎等多种功能,参与冠心病、糖尿病和高脂血症等的发生发展过程。关于脂联素与高血压的关系也有相关报道,现将近年来对于脂联素与高血压关系的研究进展综述如下。
出处 《临床荟萃》 CAS 2011年第5期455-456,共2页 Clinical Focus
基金 河北政法职业学院立项研究课题(20101006)
  • 相关文献

参考文献11

  • 1Lele RD, Joshi SR, Gupte A. Association of adipocytokines (Ieptin, adiponectin TNF-alpha). insulin and proinsulin with diabetes-the Mumbai Obesity Project (MOP) [J]. J Assoc Physicians India, 2006,54 : 689-696,.
  • 2Marso SP, Mehta SK, Frutkin A, et al. Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in nondiabetie coronary arteries [J]. Diabetes Care. 2008,31(5) :989-994.
  • 3Miyazaki T, Shimada K, Mokuno H,et al. Adipocyte derived plasma protein, adiponectin is associated with smoking status in patients with coronary artery disease[J]. Heart, 2003,89 (6) :663.
  • 4Wang X, Hattori Y, Satoh H, et al. Tetrahydrohiopterin prevents endothelial dysfunction and restores adlponect in levels in rats[J]. Eur J Pharmacol,2007, 555(1) :48-53.
  • 5童敏,李新立,徐琼,卢新政,王震震,张海锋,周艳丽,黄峻,曹克将.高血压患者血清脂联素水平和动脉顺应性的关系[J].中华高血压杂志,2007,15(6):489-492. 被引量:3
  • 6Tanida M,Shen J, Horii Y, et al. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats[J]. Exp Biol Med(Maywood), 2007, 232(3) : 390-397.
  • 7Papadopoulos DP, Perrea D, Thomopoulos C, et al. Masked hypertension and atherogenesls: the impact on adiponectin and resistin plasma levels [J]. J C/in Hypertens (Greenwich), 2009,11(2) :61-65.
  • 8宋春玲,张舒娜,刘海舟.缬沙坦对高血压合并糖尿病患者血清脂联素的影响[J].中国实用医药,2010,5(21):151-152. 被引量:4
  • 9Miura Y, Yamamoto N, Tsunekawa S,et al. Replacement of valsartan and candesartan by telmisartan in hypertensive patients with type 2 diabetes: metabolic and antiatherogenic eonsequenees[J]. Diabetes Care, 2005,28(3) :757-758.
  • 10Ebinc H,Ozkurt ZN, Ebinc FA, et al. Adiponectin and insulin resistance in obesity-related diseases[J]. J Int Med Res,2008, 36(1) :71-79.

二级参考文献12

  • 1李丙蓉,邓华聪.脂联素、球状脂联蛋白与糖尿病动脉粥样硬化[J].中国动脉硬化杂志,2005,13(6):799-802. 被引量:5
  • 2李嘉强,戴颖秀,刘玉敏,郑基,刘文斌.高血压患者血清脂联素与游离脂肪酸、糖及脂代谢[J].高血压杂志,2006,14(5):352-355. 被引量:24
  • 3[2]Ouchi N,Kihara S,Arita Y,et al.Novel modulator for endothelial adhesion molecules:adipocyte-derived plasma protein adiponectin[J].Circulation,1999,100:2473-2476.
  • 4[3]Adamczak M,Wiecek A,Funahashi T,et al.Decreased plasma adiponectin concentration in patients with essential hypertension[J].Am J Hypertens,2003,16:72-75.
  • 5[7]Mahmud A,Feely J.Adiponectin and arterial stiffness[J].Am J Hypertens,2005,18(12 Pt 1):1543-1548.
  • 6[8]Matsuda M,Shimomura I,Sata M,et al.Role of adiponectin in preventing vascular stenosis.The missing link of adipo-vascular axis[J].J Biol Chem,2002,277:37487-37491.
  • 7[9]Furuhashi M,Ura N,Higashiura K,et al.Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension[J].Hypertens,2003,42:76-81.
  • 8[10]Tsatsanis C,Zacharioudaki V,Androulidaki A,et al.Adiponectin induces TNF-α and IL-6 in macrophages and promotes tolerance to itself and other pro-inflammatory stimuli[J].Biochem Biophys Res Commun,2005,335:1254-1263.
  • 9[11]Berg AH,Scherer PE.Adipose tissue,inflammation,and cardiovascular disease[J].Circ Res,2005,96:939-949.
  • 10鲁永梅.缬沙坦对高血压合并糖尿病血清脂联素的影响[J].中国现代医生,2009,47(23):68-68. 被引量:1

共引文献5

同被引文献24

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部